Published in
Springer, Journal of Thrombosis and Thrombolysis, 2(48), p. 315-322, 2019
DOI: 10.1007/s11239-019-01891-0
Links
Tools
What are the difficulties in conducting randomised controlled trials of thromboprophylaxis in myeloma patients and how can we address these? Lessons from apixaban versus LMWH or aspirin as thromboprophylaxis in newly diagnosed multiple myeloma (TiMM) feasibility clinical trial
Journal article published in 2019 by
Zara Sayar 
,
Julia Czuprynska,
Jignesh P. Patel,
Reuben Benjamin ,
Lara N. Roberts,
Raj K. Patel,
Victoria Cornelius,
Roopen Arya
,
Julia Czuprynska,
Jignesh P. Patel,
Reuben Benjamin ,
Lara N. Roberts,
Raj K. Patel,
Victoria Cornelius,
Roopen Arya
This paper is made freely available by the publisher.
Full text: Download
Published version:
archiving forbidden
Data provided by 